SaveHealth reports on managing type 2 diabetes through medications, lifestyle changes, and support, highlighting various ...

Wall St. provides estimates for future stock prices of Eli Lilly from 2026 to 2030 based on projected revenue and net income.

Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Genentech, Gilead, GSK, Merck, Novartis and Sanofi have agreed to drug pricing deals.

New Medicare policies in 2026 could lower prescription drug costs for retirees through negotiated prices, spending caps, and ...

There’s good news in 2026 for seniors enrolled in Medicare Part D who rely on the priciest prescription drugs: 10 high-cost ...

Weight-loss drugs such as Mounjaro have been praised for triggering dramatic weight loss for about 1.6 million people in the ...

An extension study of Amgen's experimental obesity drug MariTide found that it helped people maintain weight loss while a ...

Discontinuing obesity medicines often means the weight comes back and people lose the cardiovascular and metabolic benefits ...

Weight-loss drugs such as Ozempic, Wegovy and Mounjaro work primarily by reducing hunger. They mimic a hormone the body ...

A new study finds that people who quit weight-loss medications, including GLP-1 drugs, regain weight four times faster than ...

Glucagon-like peptide-1 receptor agonists (GLP-1s or GLP-1RAs) – also known as weight-loss jabs – are medicines that help ...